InCarda Therapeutics
Latest round
- Series C
Last raised
- Oct 2020
Total raised
- $75M
Investors
- 6
About InCarda Therapeutics
Founded in 2009 and headquartered in Newark, US, InCarda Therapeutics focuses on developing inhalation therapies for cardiovascular conditions. The company was founded by Carlos Schuler and Narsi R.InCarda Therapeutics develops a unique inhalation therapy for treating acute episodes of paroxysmal atrial fibrillation (PAF). Their lead product is an orally inhaled formulation of flecainide, which directly delivers therapeutic agents to cardiac tissue, ensuring rapid action with minimized systemic exposure. This targeted delivery enhances both efficacy and safety.InCarda Therapeutics generates revenue through direct sales of its inhalation therapy products to healthcare facilities and practitioners. The sales process typically involves business-to-business arrangements, allowing healthcare providers to purchase the medication directly for administering to patients experiencing acute episodes of PAF. The company is targeting expansion in North America and Europe, aiming to establish a strong presence in these regions by the end of 2022.
Who invested in InCarda Therapeutics
6 investors across 3 rounds
See all investors in InCarda Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about InCarda Therapeutics
Who invested in InCarda Therapeutics?
InCarda Therapeutics has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InCarda Therapeutics raised?
InCarda Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did InCarda Therapeutics last raise money?
InCarda Therapeutics's most recent round on record is a Series C, in Oct 2020.
What does InCarda Therapeutics do?
Founded in 2009 and headquartered in Newark, US, InCarda Therapeutics focuses on developing inhalation therapies for cardiovascular conditions.
Where is InCarda Therapeutics headquartered?
InCarda Therapeutics is headquartered in Newark, US.
Which VCs invest in companies like InCarda Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at InCarda Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like InCarda Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.